States and cities sue over PSLF employer rule that could strip millions of public servants of promised loan relief.
Dexcom shares plunge after cautious 2026 outlook, despite strong Q3 results, as analysts cite margin pressure and uncertainty around G7 sensor uptake and accuracy.
Morgan Wallen announces 'Still the Problem' 2026 stadium tour, highlighting his continued commercial success despite past controversies.
States and cities sue over PSLF employer rule that could strip millions of public servants of promised loan relief.
Dexcom shares plunge after cautious 2026 outlook, despite strong Q3 results, as analysts cite margin pressure and uncertainty around G7 sensor uptake and accuracy.
Morgan Wallen announces 'Still the Problem' 2026 stadium tour, highlighting his continued commercial success despite past controversies.